BioAtla

0 followers


BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.

Employees

51-200

Links


Org chart

Jay Short
Chairman, Chief Executive Officer & Cofounder
Collapse
Richard Waldron
Chief Financial Officer
Eric Sievers
Chief Medical Officer
Cathy Chang
SVP, Research & Development
Monica Sullivan
SVP, Intellectual Property & Contracts
Sheri Lydick
Chief Commercial Officer
Susie Melody
SVP, Human Resources
Gerhard Frey
SVP, Technology Development

Board & advisors

Mary Ann Gray
Board Member
Eddie Williams
Member Board Of Directors
Sylvia McBrinn
Board Member
Susan Moran
Board Member
Lawrence Steinman
Board Member